NORD Statement on User Fee Reauthorization and Continuing Resolution
September 30, 2022, Washington, DC – Following the passage of H.R 6833, Peter L. Saltonstall, President and CEO of the National Organization for Rare Disorders (NORD), issued the following statement: …
Continue reading “NORD Statement on User Fee Reauthorization and Continuing Resolution”
Read more